{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:32:37Z","timestamp":1778049157544,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T00:00:00Z","timestamp":1332460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T00:00:00Z","timestamp":1332460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s00436-012-2847-4","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T01:39:12Z","timestamp":1332466752000},"page":"361-369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Therapeutic immunization with radio-attenuated Leishmania parasites through i.m. route revealed protection against the experimental murine visceral leishmaniasis"],"prefix":"10.1007","volume":"111","author":[{"given":"Sanchita","family":"Datta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhumita","family":"Manna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supriya","family":"Khanra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moumita","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhaballav","family":"Bhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anindita","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syamal","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,23]]},"reference":[{"key":"2847_CR1","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/iai.65.6.2371-2377.1997","volume":"65","author":"JF Afrin","year":"1997","unstructured":"Afrin JF, Ali N (1997) Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes. Infect Immun 65:2371\u20132377","journal-title":"Infect Immun"},{"key":"2847_CR2","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1128\/IAI.73.2.812-819.2005","volume":"73","author":"I Aguilar-Be","year":"2005","unstructured":"Aguilar-Be I, da Silva ZR, Paraguai de Souza E, Borja-Cabrera GP, Rosado-Vallado M, Mut-Martin M, Garc\u00eda-Miss Mdel R, Palatnik de Sousa CB, Dumonteil E (2005) Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis. Infect Immun 73:812\u2013900","journal-title":"Infect Immun"},{"key":"2847_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/0035-9203(82)90232-2","volume":"76","author":"J Alexander","year":"1982","unstructured":"Alexander J (1982) A radioattenuated Leishmania major vaccine markedly increases the resistance of CBA mice to subsequent infection with Leishmania mexicana mexicana. Trans R Soc Trop Med Hyg 76:646\u2013649","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2847_CR4","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1242\/jcs.112.18.2993","volume":"112","author":"J Alexander","year":"1999","unstructured":"Alexander J, Satoskar AR, Russell DG (1999) Leishmania species: models of intracellular parasitism. J Cell Sci 112:2993\u20133002","journal-title":"J Cell Sci"},{"key":"2847_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2307\/3284319","volume":"83","author":"N Ali","year":"1997","unstructured":"Ali N, Afrin JF (1997) Protection of mice against visceral leishmaniasis by immunization with promastigote antigen incorporated in liposomes. Parasitology 83:70\u201375","journal-title":"Parasitology"},{"key":"2847_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.actatropica.2004.06.006","volume":"92","author":"VS Amato","year":"2004","unstructured":"Amato VS, Rabello A, Rotondo-Silva A, Kono A, Maldonado PT, Alves IC, Floeter-Winter LM, Neto VM, Shikanai-Yasuda VA (2004) Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients. Acta Trop 92:127\u2013132","journal-title":"Acta Trop"},{"key":"2847_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1369-5274(02)00286-2","volume":"5","author":"AO Amer","year":"2002","unstructured":"Amer AO, Swanson MS (2002) A phagosome of one\u2019s own: a microbial guide to life in the macrophage. Curr Opin Microbiol 5:56\u201361","journal-title":"Curr Opin Microbiol"},{"key":"2847_CR8","first-page":"238","volume":"119","author":"A Awasthi","year":"2004","unstructured":"Awasthi A, Mathur RK, Saha B (2004) Immune response to leishmania infection. Indian J Med Res 119:238\u2013258","journal-title":"Indian J Med Res"},{"key":"2847_CR9","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.4049\/jimmunol.174.11.7160","volume":"174","author":"R Basu","year":"2005","unstructured":"Basu R, Bhaumik S, Basu JM, Naskar K, De T, Roy S (2005) Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis. J Immunol 174:7160\u20137171","journal-title":"J Immunol"},{"key":"2847_CR10","doi-asserted-by":"publisher","first-page":"5956","DOI":"10.1128\/IAI.00944-07","volume":"75","author":"R Basu","year":"2007","unstructured":"Basu R, Bhaumik S, Haldar AK, Naskar K, De T, Dana SK, Walden P, Roy S (2007) Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13. Infect Immun 75:5956\u20135966","journal-title":"Infect Immun"},{"key":"2847_CR11","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.vaccine.2008.12.053","volume":"27","author":"R Basu","year":"2009","unstructured":"Basu R, Bhaumik S, Sen S, Naskar K, Roy S (2009) KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major. Vaccine 27:1306\u20131316","journal-title":"Vaccine"},{"key":"2847_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0031182000078458","volume":"109","author":"PA Bates","year":"1994","unstructured":"Bates PA (1994) Complete developmental cycle of Leishmania mexicana in axenic culture. Parasitology 109:1\u20139","journal-title":"Parasitology"},{"key":"2847_CR13","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1002\/eji.200839017","volume":"39","author":"SK Bhaumik","year":"2009","unstructured":"Bhaumik SK, Naskar K, De T (2009) Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donavani promastigotes involves Th1-immunity and down regulation of IL-10. Eur J Immunol 39:2146\u20132160","journal-title":"Eur J Immunol"},{"key":"2847_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0065-2776(08)60536-2","volume":"54","author":"RL Coffman","year":"1999","unstructured":"Coffman RL, Lehman DA, Rothman P (1999) Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol 54:229\u2013270","journal-title":"Adv Immunol"},{"key":"2847_CR15","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","volume":"180","author":"KN Couper","year":"2008","unstructured":"Couper KN, Blount DG, Riley EM (2008) IL-10: the master regulator of immunity to infection. J Immunol 180:5771\u20135772","journal-title":"J Immunol"},{"key":"2847_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","volume":"10","author":"SL Croft","year":"2006","unstructured":"Croft SL, Sundar S, Fairlamb AH (2006) Drug resistance in leishmaniasis. Clin Microbiol Rev 10:111\u2013126","journal-title":"Clin Microbiol Rev"},{"key":"2847_CR17","unstructured":"Datta S, Naskar K, Chakraborty A, Manna M (2010) Immunotherapeutic role of radio attenuated Leishmania parasites in experimental murine leishmaniasis. Medimond International Proceedings (no.M815S7113). 12th International Congress on Parasitology, Melbourne, Australia"},{"key":"2847_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.exppara.2011.10.001","volume":"130","author":"S Datta","year":"2012","unstructured":"Datta S, Adak R, Chakraborty P, Haldar AK, Bhattacharjee S, Chakraborty A, Roy S, Manna M (2012) Radio-attenuated leishmanial parasites as immunoprophylactic agent against experimental murine visceral leishmaniasis. Exp Parasitol 130:39\u201347","journal-title":"Exp Parasitol"},{"key":"2847_CR19","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1002\/eji.200839017","volume":"39","author":"T De","year":"2009","unstructured":"De T, Bhaumik SK, Naskar K (2009) Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10. Eur J Immunol 39:2146\u20132160","journal-title":"Eur J Immunol"},{"key":"2847_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","volume":"27","author":"P Desjeux","year":"2004","unstructured":"Desjeux P (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27:305\u2013318","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"2847_CR21","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/infdis\/jir461","volume":"204","author":"S Gautam","year":"2011","unstructured":"Gautam S, Kumar R, Maurya R, Nyl\u00e9n S, Ansari N, Rai M, Sundar S, Sacks D (2011) IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis. J Infect Dis 204:1134\u20131137","journal-title":"J Infect Dis"},{"key":"2847_CR22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1172\/JCI116570","volume":"92","author":"HW Ghalib","year":"1993","unstructured":"Ghalib HW, Piuvezam MR, Skeiky YA, Siddig M, Hashim FA, El-Hassan AM, Russo DM, Reed SG (1993) Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 92:324\u2013329","journal-title":"J Clin Invest"},{"key":"2847_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0008-8749(85)90081-4","volume":"94","author":"RM Gorczynski","year":"1985","unstructured":"Gorczynski RM (1985) Immunization of susceptible BALB\/c mice against Leishmania braziliensis. II. Use of temperature-sensitive avirulent clones of parasite for vaccination purposes. Cell Immunol 94:11\u201320","journal-title":"Cell Immunol"},{"key":"2847_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","volume":"26","author":"LC Green","year":"1982","unstructured":"Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite and [15 N]nitrate in biological fluids. Anal Biochem 26:131\u2013138","journal-title":"Anal Biochem"},{"key":"2847_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.exppara.2009.02.001","volume":"122","author":"AK Haldar","year":"2009","unstructured":"Haldar AK, Banerjee S, Naskar K, Kalita D, Islam NS, Roy S (2009) Sub-optimal dose of sodium antimony gluconate (SAG)-diperoxovanadate combination clears organ parasites from BALB\/c mice infected with antimony resistant Leishmania donovani by expanding antileishmanial T-cell repertoire and increasing IFN-gamma to IL-10 ratio. Exp Parasitol 122:145\u2013154","journal-title":"Exp Parasitol"},{"key":"2847_CR26","doi-asserted-by":"publisher","unstructured":"Heravi SV, Jaafari MR, Khamesipour A, Jalali SA, Firouzmand H, Abbasi A, Badiee A (2012) Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis. Parasitol Res. doi:10.1007\/s00436-011-2806-5","DOI":"10.1007\/s00436-011-2806-5"},{"key":"2847_CR27","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.4049\/jimmunol.129.5.2206","volume":"129","author":"JG Howard","year":"1982","unstructured":"Howard JG, Stephen N, Hale C, Liew FY (1982) Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection. J Immunol 129:2206\u20132212","journal-title":"J Immunol"},{"key":"2847_CR28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4049\/jimmunol.132.1.450","volume":"132","author":"JG Howard","year":"1984","unstructured":"Howard JG, Liew FY, Hale C, Stephen N (1984) Prophylactic immunization against experimental leishmaniasis. II. Further characterization of the protectic immunity against fatal Leishmania tropica infection induced by irradiated promastigotes. J Immunol 132:450\u2013455","journal-title":"J Immunol"},{"key":"2847_CR29","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1172\/JCI116372","volume":"91","author":"CL Karp","year":"1993","unstructured":"Karp CL, El-Safi SH, Wynn TA, Satti MM, Kordofani AM, Hashim FA, Hag-Ali M, Neva FA, Nutman TB, Sacks DL (1993) In vivo cytokine profiles in patients with kala azar. Marked elevation of both interleukin-10 and interferon-gamma. J Clin Invest 91:1644\u20131648","journal-title":"J Clin Invest"},{"key":"2847_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0165-2478(98)00132-1","volume":"65","author":"A Kharazmi","year":"1999","unstructured":"Kharazmi A, Kemp K, Ismail A (1999) T-cell response in human leishmaniasis. Immunol Lett 65:105\u2013108","journal-title":"Immunol Lett"},{"key":"2847_CR31","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1128\/iai.61.12.5205-5213.1993","volume":"61","author":"PB Kimsey","year":"1993","unstructured":"Kimsey PB, Theodos CM, Mitchen TK, Turco SJ, Titus RG (1993) An avirulent lipophosphoglycan-deficient Leishmania major clone induces CD4+ T cells which protect susceptible BALB\/c mice against infection with virulent L. major. Infect Immun 61:5205\u20135213","journal-title":"Infect Immun"},{"key":"2847_CR32","first-page":"892817","volume":"2012","author":"JE Krystal","year":"2011","unstructured":"Krystal JE, Lukasz K (2011) Development of vaccines against visceral leishmaniasis. J Trop Med 2012:892817","journal-title":"J Trop Med"},{"key":"2847_CR33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0014-4894(74)90019-8","volume":"35","author":"A Lemma","year":"1974","unstructured":"Lemma A, Cole L (1974) Leishmania enrrietti: radiation effects and evaluation of radioattenuated organisms for vaccination. Exp Parasitol 35:161\u2013169","journal-title":"Exp Parasitol"},{"key":"2847_CR34","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.4049\/jimmunol.135.3.2095","volume":"135","author":"FY Liew","year":"1985","unstructured":"Liew FY, Hale C, Howard JG (1985) Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection. J Immunol 135:2095\u20132101","journal-title":"J Immunol"},{"key":"2847_CR35","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.144.12.4794","volume":"12","author":"FY Liew","year":"1990","unstructured":"Liew FY, Millott S, Parkinson C, Palmer RM, Moncada S (1990) Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from l-arginine. J Immunol 12:4794\u20134797","journal-title":"J Immunol"},{"key":"2847_CR36","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1371\/journal.pntd.0000114","volume":"1","author":"CD Mathers","year":"2007","unstructured":"Mathers CD, Ezzati M, Lopez AD (2007) Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis 1:114","journal-title":"PLoS Negl Trop Dis"},{"key":"2847_CR37","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nm1045","volume":"10","author":"RK Mathur","year":"2004","unstructured":"Mathur RK, Awasthi A, Wadhone P, Ramanamurthy B, Saha B (2004) Reciprocal CD40 signals through p38MAPK and ERK-1\/2 induce counteracting immune response. Nat Med 10:540\u2013544","journal-title":"Nat Med"},{"key":"2847_CR38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0006-2952(94)90014-0","volume":"47","author":"R Mukhopadhyay","year":"1994","unstructured":"Mukhopadhyay R, Madhubala R (1994) Antileishmanial activity and modification of hepatic xenobiotic metabolizing enzymes in golden hamster by 2(3)-tert-butyl-4-hydroxyanisole following infection with Leishmania donovani. Biochem Pharmacol 47:253\u2013256","journal-title":"Biochem Pharmacol"},{"key":"2847_CR39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0264-410X(98)90017-2","volume":"17","author":"S Mukhopadhyay","year":"1999","unstructured":"Mukhopadhyay S, Sen P, Bhattacharyya S, Majumdar S, Roy S (1999) Immunoprophylaxis and immunotherapy against experimental visceral leishmaniasis. Vaccine 17:291\u2013300","journal-title":"Vaccine"},{"key":"2847_CR40","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1084\/jem.160.2.600","volume":"160","author":"CF Nathan","year":"1984","unstructured":"Nathan CF, Prendergast TJ, Wiebe ME, Stanley ER, Platzer E, Remold HG, Welte K, Rubin BY, Murray HW (1984) Activation of human macrophages. Comparison of other cytokines with interferon-gamma. J Exp Med 160:600\u2013605","journal-title":"J Exp Med"},{"key":"2847_CR41","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","volume":"28","author":"S Nylen","year":"2007","unstructured":"Nylen S, Sacks D (2007) Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol 28:378\u2013384","journal-title":"Trends Immunol"},{"key":"2847_CR42","doi-asserted-by":"publisher","unstructured":"Oliveira DM, Costa MA, Chavez-Fumagalli MA, Valadares DG, Duarte MC, Costa LE, Martins VT, Gomes RF, Melo MN, Soto M, Tavares CA, Coelho EA (2011) Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB\/c mice using different doses and routes of inoculation of parasites. Parasitol Res. doi:10.1007\/s00436-011-2628-5","DOI":"10.1007\/s00436-011-2628-5"},{"key":"2847_CR43","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1093\/nar\/21.18.4305","volume":"21","author":"B Papadopoulou","year":"1993","unstructured":"Papadopoulou B, Roy G, Ouellette M (1993) Frequent amplification of a short chain dehydrogenase gene as part of circular and linear amplicons in methotrexate resistant Leishmania. Nucleic Acids Res 21:4305\u20134312","journal-title":"Nucleic Acids Res"},{"key":"2847_CR44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-3024.1993.tb00587.x","volume":"15","author":"D Rivier","year":"1993","unstructured":"Rivier D, Shah R, Bovay P, Mauel J (1993) Vaccine development against cutaneous leishmaniasis: subcutaneous administration of radioattenuated parasites protects CBA mice against virulent Leishmania major challenge. Parasite Immunol 15:75\u201384","journal-title":"Parasite Immunol"},{"key":"2847_CR45","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1046\/j.1365-3024.1999.00244.x","volume":"21","author":"D Rivier","year":"1999","unstructured":"Rivier D, Bovay P, Shah R, Didisheim S, Mauel J (1999) Vaccine against Leishmania major in a CBA mouse model of infection: role of adjuvants and mechanism of protection. Parasite Immunol 21:461\u2013473","journal-title":"Parasite Immunol"},{"key":"2847_CR46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","volume":"21","author":"R Sabat","year":"2010","unstructured":"Sabat R, Grutz G, Warszawska K (2010) Biology of interleukin-10. Cytokine Growth Factor Rev 21:331\u2013344","journal-title":"Cytokine Growth Factor Rev"},{"key":"2847_CR47","first-page":"851","volume":"2007","author":"R Silvestre","year":"2007","unstructured":"Silvestre R, Santar\u00e9m N, Tavares J, Silva M, Cabral S, Maciel J, Cordeiro-da-Silva A (2007) Immune response regulation by leishmania secreted and nonsecreted antigens. J Biomed Biotechnol 2007:851\u2013854","journal-title":"J Biomed Biotechnol"},{"key":"2847_CR48","doi-asserted-by":"publisher","unstructured":"Srividya G, Kulshrestha A, Singh R, Salotra P (2011) Diagnosis of visceral leishmaniasis: developments over the last decade. Parasitol Res. doi:10.1007\/s00436-011-2680-1","DOI":"10.1007\/s00436-011-2680-1"},{"key":"2847_CR49","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.4049\/jimmunol.165.12.7064","volume":"165","author":"S Stager","year":"2000","unstructured":"Stager S, Smith DF, Kaye PM (2000) Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis. J Immunol 165:7064\u20137071","journal-title":"J Immunol"},{"key":"2847_CR50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2307\/3275662","volume":"49","author":"LA Stauber","year":"1963","unstructured":"Stauber LA (1963) Some aspects of immunity to intracellular protozoan parasites. J Parasitol 49:3\u201311","journal-title":"J Parasitol"},{"key":"2847_CR51","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.4049\/jimmunol.175.4.2517","volume":"175","author":"CB Stober","year":"2005","unstructured":"Stober CB, Lange UG, Roberts MTM, Alcami A, Blackwell JM (2005) IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection. J Immunol 175:2517\u20132524","journal-title":"J Immunol"},{"key":"2847_CR52","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","volume":"6","author":"S Sundar","year":"2001","unstructured":"Sundar S (2001) Drug resistances in Indian visceral leishmaniasis. Trop Med Int Health 6:849\u2013854","journal-title":"Trop Med Int Health"},{"key":"2847_CR53","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1179\/000349802125000466","volume":"96","author":"S Sundar","year":"2002","unstructured":"Sundar S, Singh N, Singh RT (2002) Identification of a gene linked to drug resistance in field isolates of Leishmania donovani. Ann Trop Med Parasitol 96:839\u2013841","journal-title":"Ann Trop Med Parasitol"},{"key":"2847_CR54","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.immuni.2004.10.012","volume":"21","author":"M Svensson","year":"2004","unstructured":"Svensson M, Maroof A, Ato M, Kaye PM (2004) Stromal cells direct local differentiation of regulatory dendritic cells. Immunity 21:805\u2013816","journal-title":"Immunity"},{"key":"2847_CR55","first-page":"12","volume-title":"World Health Organization report on Leishmania and HIV in gridlock","author":"WHO\/UNAIDS","year":"1998","unstructured":"WHO\/UNAIDS (1998) World Health Organization report on Leishmania and HIV in gridlock. WHO\/UNAIDS report, Geneva, pp 12\u201325"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-012-2847-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-012-2847-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-012-2847-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-012-2847-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T18:32:14Z","timestamp":1684866734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-012-2847-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,23]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["2847"],"URL":"https:\/\/doi.org\/10.1007\/s00436-012-2847-4","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,23]]},"assertion":[{"value":"22 December 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}